US 7772239
Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists
granted A61KA61K31/46A61K31/496
Quick answer
US patent 7772239 (Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists) held by Theravance, Inc. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/46, A61K31/496, A61P, A61P1/00